期刊文献+

进展期胃肠间质瘤综合治疗研究进展

下载PDF
导出
摘要 随着对胃肠间质瘤认识的提高,诊断为GIST的患者比例逐年升高。因为GIST患者手术后易复发,因此,对于中高危间质瘤患者术后给予靶向药物治疗是必要的。本文重点介绍了间质瘤的术后靶向治疗方案及综合治疗方案。对于进展期间质瘤患者,伊马替尼为公认的一线靶向药物,其次为索坦及其他新型靶向药物。手术治疗联合TKI抑制剂治疗为主的综合治疗可能为更多的GIST患者带来福音。
出处 《当代医学》 2015年第12期20-21,共2页 Contemporary Medicine
  • 相关文献

参考文献16

  • 1Mazur MT,Clark HB.Gastric stromal tumors:reappraisal of histogenesis[J]. Am J Surg Pathol,1983,7(6):507-519.
  • 2Sleijfer S,Wiemer E,Verweij J.Drug insight:gastrointestinal stromal tumors(GIST)-the solid tumor model for cancer-specific treatment[J].Nat Clin Praet Oncol 2008,5(2):102-111.
  • 3P ossi CR,Mocellin S,Mencarelli l ,et aI.Gastrofntestinal stromal tumors:from a surgical to a molecular approach[J].nt J Cancer, 2003, 107(2):171-176.
  • 4Langer C,Gunawan B,Schufer P,et al.Prognostic factors influencfng surgical management and outcome of gastrointestinal stromal tumors[J].Br J Surg,2005,90(5):532-339.
  • 5Gold JS,Gonen M,Gutierrez A,et al.Development and validation of a prognostic nomogram for recurrence--free survival after complete surgical resection of Iocalised primary gastrointestinal stromal tumour:a retrospective analysis[J].Lancet Oncol, 2009,10(11):1045-1052.
  • 6Joensuu H,aoberts PJ,$arlomo-Eikanla M,et al.Effect of the tyrosinekinase inhibitor ST1571 in a patient with metastatic gastrointestinal stromal tumor[J].N Engl J Meal,2001,344(14):1052--1056.
  • 7Dematteo RP,Ballman KV,Antonescu CE,et aI.Adjuwnt imatinib mesylate after resection of Iocalised,primary gastrointestinal strom l tumour,a randomised,double-blind,placebo-controlled trial[J].Lanc et 2009 373(9669).1097-1104.
  • 8Demetri OD,von Mehren M,Antonescu CP ,et aI.NCCN Task Force report:update on the management of patients with gastrointestinal stromal tumors[J].J Natl Compr Canc Netw,2OlO,8(Suppl 2):S 1-41.
  • 9Corless C,Ballman K,Antonescu C ,et al.Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI $tromai tumor:the ACOSOG Z9001 trial[J].J ODin 0ncol,2014,32(15): 1565-1570.
  • 10Debiec-laychter M,Dumez H,Judson,et al.Use of C--KIT/PDGFFta mutationa] anayisis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours enterd on phase I and I] stdudies of the EOFITC Soft Tissue and Bone Sarcoma Group[J].Eur J Cancer, 2004,40(5): 689-695.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部